There have been 26 recent insider transactions recorded for Oncolytics Biotech Inc. (ONCY), including 14 buys and 0 sells. Total insider buying was valued at $362.62K and total insider selling at RSU Award.
Notable insiders with recent activity include Kelly Jared, Parsons James T., Andrews Patricia S. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — ONCY
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-12 |
Kelly Jared |
Chief Executive Officer |
Informative Buy |
5,050 |
$0.96 |
$4.85K |
114,050 |
| 2026-03-11 |
Parsons James T. |
Director |
Informative Buy |
10,000 |
$1.03 |
$10.3K |
41,849 |
| 2026-02-12 |
Andrews Patricia S |
Director |
Informative Buy |
35,400 |
$0.86 |
$30.29K |
78,128 |
| 2026-02-12 |
Pisano Wayne |
Director |
Informative Buy |
30,000 |
$0.84 |
$25.34K |
492,414 |
| 2026-02-12 |
Seizinger Bernd R. |
Director |
Informative Buy |
40,000 |
$0.85 |
$33.86K |
566,991 |
| 2026-02-12 |
Heineman Thomas Charles |
Chief Medical Officer |
Informative Buy |
12,132 |
$0.83 |
$10.03K |
282,818 |
| 2026-02-12 |
Brown Deborah Margaret |
Director |
Informative Buy |
25,000 |
$0.85 |
$21.24K |
109,851 |
| 2026-02-12 |
Kelly Jared |
Chief Executive Officer |
Informative Buy |
29,500 |
$0.84 |
$24.84K |
109,000 |
| 2026-02-12 |
Look Kirk |
Chief Financial Officer |
Informative Buy |
12,000 |
$0.84 |
$10.1K |
287,515 |
| 2026-02-12 |
Hagerman Allison |
VP, Product Development |
Informative Buy |
10,000 |
$0.83 |
$8.3K |
115,059 |
| 2026-02-11 |
Seizinger Bernd R. |
Director |
Informative Buy |
60,000 |
$0.83 |
$49.59K |
526,991 |
| 2026-02-11 |
Aromando Andrew |
Chief Business Officer |
Informative Buy |
29,600 |
$0.86 |
$25.42K |
55,100 |
| 2026-02-11 |
Kelly Jared |
Chief Executive Officer |
Informative Buy |
5,600 |
$0.84 |
$4.68K |
79,500 |
| 2026-01-16 |
Seizinger Bernd R. |
Director |
Informative Buy |
100,000 |
$1.04 |
$103.77K |
466,991 |
| 2026-01-01 |
Rigby Jonathan |
Director |
Unknown |
45,000 |
$1.84 |
$82.8K |
- |
| 2026-01-01 |
Andrews Patricia S |
Director |
Unknown |
30,000 |
$1.08 |
$32.4K |
- |
| 2026-01-01 |
Pisano Wayne |
Director |
Unknown |
37,500 |
$2.76 |
$103.5K |
- |
| 2026-01-01 |
Parsons James T. |
Director |
Unknown |
45,000 |
$1.14 |
$51.3K |
- |
| 2026-01-01 |
Seizinger Bernd R. |
Director |
Unknown |
30,000 |
$1.08 |
$32.4K |
- |
| 2026-01-01 |
Aromando Andrew |
Chief Business Officer |
Unknown |
250,000 |
$0.99 |
$247.5K |
- |
| 2026-01-01 |
Holtham Angela |
Director |
Unknown |
30,000 |
$1.14 |
$34.2K |
- |
| 2026-01-01 |
Heineman Thomas Charles |
Chief Medical Officer |
Unknown |
570,000 |
$1.08 |
$615.6K |
- |
| 2026-01-01 |
Brown Deborah Margaret |
Director |
Unknown |
5,263 |
$5.42 |
$28.53K |
- |
| 2026-01-01 |
Kelly Jared |
Chief Executive Officer |
Unknown |
2,850,000 |
$0.57 |
$1.62M |
- |
| 2026-01-01 |
Look Kirk |
Chief Financial Officer |
Unknown |
570,000 |
$1.08 |
$615.6K |
- |
| 2026-01-01 |
Hagerman Allison |
VP, Product Development |
Unknown |
240,000 |
$1.08 |
$259.2K |
- |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
